Replies to post #34179 on Humanigen Inc (fka HGENQ)

[DonDonDonDon]

The issue is if we are ALL in with Covid only and do not get the approvals we are below $3.. we all know that LENZ is real and is needed but the politics overpowers what maybe best. It’s all about vaccines as the big pharms have the bigger pockets for the lobbyist. Currently there is zero interest in Therapeutics. Sad but true

The CAR-T trial is moving right along. The trials for our other indications are moving right along, too. CAR-T and Covid aren't mutually exclusive indications. We can pursue both.

CAR-T provides a floor to the share price. I doubt $3 is even possible with how positive the CAR-T trial is looking. CAR-T alone is worth more than out current market cap. But if we do fall to $3 after Covid rejections, CAR-T will bring the share price right back up. So Covid has the potential to bring the share price to $30 in the short term and CAR-T makes HGEN a safe long term investment in the case Covid doesn't pan out.